Sarcopenia During Androgen-Deprivation Therapy for Prostate Cancer

PURPOSE: To characterize changes in lean body mass (LBM) in men with prostate cancer receiving androgen-deprivation therapy (ADT). PATIENTS AND METHODS: We prospectively evaluated LBM in a prespecified substudy of a randomized controlled trial of denosumab to prevent fractures in men receiving ADT f...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Smith, Matthew R., Saad, Fred, Egerdie, Blair, Sieber, Paul R., Tammela, Teuvo L.J., Ke, Chunlei, Leder, Benjamin Z., Goessl, Carsten
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2012
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3434987/
https://ncbi.nlm.nih.gov/pubmed/22649143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.38.8850
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars